Edward Walsh
Concepts (339)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Respiratory Syncytial Virus Infections | 34 | 1994 | 35 |
Why?
| Respiratory Syncytial Viruses | 54 | 1983 | 33 |
Why?
| Antibodies, Viral | 45 | 1984 | 104 |
Why?
| Respiratory Syncytial Virus, Human | 19 | 1994 | 15 |
Why?
| Metapneumovirus | 7 | 2003 | 6 |
Why?
| Viral Envelope Proteins | 25 | 1984 | 26 |
Why?
| Paramyxoviridae Infections | 7 | 1999 | 12 |
Why?
| Respiratory Tract Infections | 16 | 1983 | 57 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 14 | 2001 | 243 |
Why?
| Influenza A virus | 11 | 1987 | 63 |
Why?
| Viral Fusion Proteins | 19 | 1985 | 9 |
Why?
| Influenza, Human | 12 | 1987 | 94 |
Why?
| Viral Proteins | 23 | 1983 | 71 |
Why?
| Viral Vaccines | 12 | 1986 | 35 |
Why?
| Neutralization Tests | 22 | 1983 | 37 |
Why?
| Antigens, Viral | 21 | 1985 | 53 |
Why?
| HN Protein | 9 | 1988 | 10 |
Why?
| Aged | 40 | 1990 | 988 |
Why?
| Antibodies, Neutralizing | 3 | 2009 | 11 |
Why?
| Epitopes | 7 | 1986 | 86 |
Why?
| Respirovirus Infections | 23 | 1983 | 22 |
Why?
| Nasal Mucosa | 11 | 1986 | 22 |
Why?
| Influenza B virus | 2 | 2007 | 16 |
Why?
| Aged, 80 and over | 22 | 1992 | 599 |
Why?
| Antibody-Producing Cells | 3 | 2010 | 20 |
Why?
| Antiviral Agents | 5 | 1983 | 91 |
Why?
| Immunoglobulin G | 20 | 1984 | 191 |
Why?
| Adult | 34 | 1983 | 1317 |
Why?
| Humans | 83 | 1983 | 1856 |
Why?
| Pulmonary Disease, Chronic Obstructive | 2 | 2005 | 25 |
Why?
| Middle Aged | 27 | 1996 | 1161 |
Why?
| Respiratory Syncytial Virus Vaccines | 2 | 2008 | 6 |
Why?
| Immunity, Humoral | 2 | 2009 | 12 |
Why?
| Female | 41 | 1983 | 1643 |
Why?
| Male | 39 | 1983 | 1553 |
Why?
| Mupirocin | 1 | 2010 | 4 |
Why?
| RNA, Viral | 4 | 2001 | 91 |
Why?
| Prospective Studies | 11 | 1990 | 545 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 5 |
Why?
| Antibodies, Monoclonal | 14 | 1983 | 241 |
Why?
| Infection Control | 1 | 2010 | 20 |
Why?
| Influenza Vaccines | 3 | 2007 | 70 |
Why?
| Surgical Wound Infection | 1 | 2010 | 41 |
Why?
| Epitope Mapping | 1 | 2010 | 21 |
Why?
| Cardiac Surgical Procedures | 1 | 2010 | 35 |
Why?
| Hospitalization | 9 | 1997 | 169 |
Why?
| Staphylococcal Infections | 1 | 2010 | 63 |
Why?
| Capsid Proteins | 1 | 2009 | 19 |
Why?
| Oncogene Proteins, Viral | 1 | 2009 | 29 |
Why?
| Pneumonia, Viral | 2 | 2005 | 17 |
Why?
| Immunoenzyme Techniques | 7 | 1987 | 125 |
Why?
| Anti-Bacterial Agents | 2 | 2007 | 195 |
Why?
| Heart Failure | 2 | 1999 | 106 |
Why?
| Coronavirus Infections | 3 | 1999 | 10 |
Why?
| Inpatients | 4 | 1990 | 46 |
Why?
| Homes for the Aged | 4 | 1992 | 25 |
Why?
| Disease Outbreaks | 3 | 1990 | 61 |
Why?
| Coronavirus | 2 | 2003 | 8 |
Why?
| Nursing Homes | 5 | 1990 | 55 |
Why?
| Immunoglobulin A, Secretory | 5 | 1986 | 11 |
Why?
| New York | 8 | 1990 | 422 |
Why?
| Vaccination | 7 | 1986 | 92 |
Why?
| DNA, Viral | 1 | 2007 | 98 |
Why?
| Yellow fever virus | 3 | 1985 | 3 |
Why?
| Virus Shedding | 1 | 2003 | 8 |
Why?
| Specimen Handling | 2 | 1999 | 52 |
Why?
| Severe Acute Respiratory Syndrome | 1 | 2003 | 9 |
Why?
| Sensitivity and Specificity | 6 | 1999 | 427 |
Why?
| Aging | 3 | 1986 | 275 |
Why?
| Virus Diseases | 2 | 1992 | 50 |
Why?
| Incidence | 4 | 1990 | 336 |
Why?
| Membrane Glycoproteins | 8 | 1986 | 154 |
Why?
| Young Adult | 5 | 2008 | 380 |
Why?
| Enzyme-Linked Immunosorbent Assay | 14 | 1986 | 224 |
Why?
| Vaccines, Synthetic | 2 | 1994 | 30 |
Why?
| Lung Diseases, Obstructive | 1 | 1999 | 30 |
Why?
| Immunization, Passive | 5 | 1984 | 39 |
Why?
| Infant | 17 | 1983 | 464 |
Why?
| Frail Elderly | 1 | 1999 | 29 |
Why?
| Glycoproteins | 11 | 1983 | 113 |
Why?
| Amino Acid Sequence | 3 | 1998 | 319 |
Why?
| Vero Cells | 4 | 1990 | 20 |
Why?
| Yellow Fever | 2 | 1985 | 4 |
Why?
| Antibody Formation | 6 | 1987 | 89 |
Why?
| Diagnosis, Differential | 3 | 2003 | 402 |
Why?
| Leukocytes, Mononuclear | 4 | 1991 | 67 |
Why?
| Cohort Studies | 3 | 2003 | 332 |
Why?
| Immunologic Memory | 2 | 2005 | 51 |
Why?
| Administration, Intranasal | 4 | 1994 | 25 |
Why?
| Immunization | 5 | 1987 | 85 |
Why?
| Animals | 23 | 1983 | 1031 |
Why?
| Molecular Sequence Data | 3 | 1998 | 404 |
Why?
| Immunoglobulin A | 5 | 1986 | 39 |
Why?
| B-Lymphocytes | 3 | 1999 | 134 |
Why?
| Ribavirin | 4 | 1983 | 23 |
Why?
| Mice, Inbred BALB C | 5 | 1985 | 176 |
Why?
| Heart Diseases | 3 | 2002 | 92 |
Why?
| Chronic Disease | 3 | 1997 | 267 |
Why?
| Interferon-gamma | 2 | 2005 | 133 |
Why?
| Lung Diseases | 3 | 2002 | 112 |
Why?
| Cell Transformation, Viral | 3 | 1987 | 35 |
Why?
| Mice | 11 | 1985 | 623 |
Why?
| Chlamydophila pneumoniae | 1 | 1993 | 9 |
Why?
| Immunity, Mucosal | 3 | 1999 | 16 |
Why?
| Chlamydia Infections | 1 | 1993 | 17 |
Why?
| Mutation | 3 | 1983 | 340 |
Why?
| Nasopharynx | 2 | 2003 | 27 |
Why?
| Risk Factors | 6 | 1990 | 555 |
Why?
| Cell Line | 9 | 1983 | 375 |
Why?
| Time Factors | 6 | 1987 | 896 |
Why?
| Treatment Outcome | 3 | 2007 | 661 |
Why?
| Confounding Factors (Epidemiology) | 2 | 1990 | 49 |
Why?
| Bystander Effect | 1 | 2011 | 3 |
Why?
| Viral Load | 3 | 2003 | 53 |
Why?
| Enzyme-Linked Immunospot Assay | 1 | 2010 | 2 |
Why?
| Ointments | 1 | 2010 | 11 |
Why?
| Hep G2 Cells | 1 | 2010 | 9 |
Why?
| Vancomycin | 1 | 2010 | 23 |
Why?
| Antibiotic Prophylaxis | 1 | 2010 | 22 |
Why?
| Capsid | 1 | 1990 | 14 |
Why?
| Viral Core Proteins | 1 | 1990 | 14 |
Why?
| Cholera Toxin | 3 | 1993 | 17 |
Why?
| Antigens, Surface | 1 | 1990 | 51 |
Why?
| Molecular Weight | 6 | 1983 | 154 |
Why?
| Retrospective Studies | 2 | 2005 | 653 |
Why?
| Glycosaminoglycans | 1 | 2009 | 20 |
Why?
| Vaccines, Virosome | 1 | 2009 | 3 |
Why?
| RNA Interference | 1 | 2010 | 75 |
Why?
| Respiratory Insufficiency | 1 | 2009 | 40 |
Why?
| Alum Compounds | 1 | 2008 | 5 |
Why?
| Severity of Illness Index | 3 | 2007 | 358 |
Why?
| Recombinant Fusion Proteins | 2 | 1994 | 189 |
Why?
| Research Design | 1 | 2010 | 169 |
Why?
| Rimantadine | 1 | 2007 | 7 |
Why?
| Zanamivir | 1 | 2007 | 9 |
Why?
| Oseltamivir | 1 | 2007 | 8 |
Why?
| Protein Structure, Tertiary | 1 | 2009 | 163 |
Why?
| Amantadine | 1 | 2007 | 19 |
Why?
| Centers for Disease Control and Prevention (U.S.) | 1 | 2007 | 20 |
Why?
| Models, Molecular | 1 | 2009 | 102 |
Why?
| Pharynx | 1 | 2007 | 23 |
Why?
| Double-Blind Method | 5 | 1983 | 274 |
Why?
| Acute Disease | 3 | 1992 | 271 |
Why?
| Age Factors | 4 | 1990 | 480 |
Why?
| Health Services for the Aged | 1 | 2007 | 29 |
Why?
| Respirovirus | 1 | 2006 | 7 |
Why?
| Rhinovirus | 1 | 2006 | 11 |
Why?
| Child, Preschool | 6 | 1983 | 554 |
Why?
| Risk Assessment | 1 | 2010 | 324 |
Why?
| Nose | 1 | 2006 | 31 |
Why?
| Orthomyxoviridae | 1 | 2006 | 34 |
Why?
| Antibody Specificity | 5 | 1986 | 71 |
Why?
| Interleukin-10 | 1 | 2005 | 38 |
Why?
| Encephalitis | 1 | 1985 | 29 |
Why?
| Health Services | 1 | 2005 | 44 |
Why?
| Predictive Value of Tests | 1 | 2007 | 321 |
Why?
| Adjuvants, Immunologic | 3 | 1993 | 73 |
Why?
| Long-Term Care | 1 | 2005 | 38 |
Why?
| Practice Guidelines as Topic | 1 | 2007 | 174 |
Why?
| Virus Cultivation | 1 | 2003 | 24 |
Why?
| Seroepidemiologic Studies | 2 | 1998 | 12 |
Why?
| Hong Kong | 1 | 2003 | 11 |
Why?
| Chromatography, Affinity | 3 | 1984 | 49 |
Why?
| Causality | 1 | 2003 | 42 |
Why?
| World Health Organization | 1 | 2003 | 19 |
Why?
| Seasons | 3 | 1990 | 64 |
Why?
| Cough | 1 | 2002 | 20 |
Why?
| Vaccines, Attenuated | 3 | 1986 | 22 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2005 | 113 |
Why?
| Antigen-Antibody Complex | 3 | 1983 | 34 |
Why?
| Common Cold | 1 | 2002 | 8 |
Why?
| United States | 2 | 2007 | 604 |
Why?
| Infant, Newborn | 6 | 1983 | 389 |
Why?
| Fever | 1 | 2002 | 65 |
Why?
| Blotting, Western | 2 | 1989 | 275 |
Why?
| Apolipoproteins | 1 | 2001 | 19 |
Why?
| Recurrence | 5 | 1985 | 261 |
Why?
| Antigens, CD14 | 1 | 2000 | 9 |
Why?
| Immunoglobulin E | 1 | 2001 | 28 |
Why?
| Cytokines | 2 | 2000 | 207 |
Why?
| Follow-Up Studies | 1 | 2005 | 553 |
Why?
| Lung | 6 | 1983 | 232 |
Why?
| C-Reactive Protein | 1 | 2001 | 54 |
Why?
| Drosophila Proteins | 1 | 2000 | 23 |
Why?
| Picornaviridae Infections | 1 | 1999 | 9 |
Why?
| Immunocompromised Host | 1 | 2000 | 70 |
Why?
| Arvicolinae | 4 | 1984 | 4 |
Why?
| Adolescent | 5 | 2000 | 891 |
Why?
| Dose-Response Relationship, Immunologic | 2 | 1994 | 37 |
Why?
| Formaldehyde | 3 | 1986 | 18 |
Why?
| Confidence Intervals | 1 | 1999 | 104 |
Why?
| Receptors, Cell Surface | 1 | 2000 | 115 |
Why?
| Attachment Sites, Microbiological | 1 | 1998 | 5 |
Why?
| Neoplasms, Experimental | 1 | 1999 | 72 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 36 |
Why?
| Kinetics | 2 | 1990 | 349 |
Why?
| Cross Reactions | 4 | 1987 | 63 |
Why?
| Complement System Proteins | 2 | 1985 | 30 |
Why?
| Cells, Cultured | 4 | 1985 | 447 |
Why?
| Binding, Competitive | 2 | 1986 | 109 |
Why?
| Logistic Models | 2 | 2009 | 251 |
Why?
| Safety | 1 | 1997 | 80 |
Why?
| Asthma | 1 | 2001 | 97 |
Why?
| Disease Transmission, Infectious | 1 | 1996 | 12 |
Why?
| Risk | 1 | 1998 | 203 |
Why?
| Aerosols | 3 | 1983 | 39 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 1983 | 167 |
Why?
| Macrophages | 3 | 1985 | 148 |
Why?
| Reproducibility of Results | 1 | 1999 | 391 |
Why?
| Tumor Cells, Cultured | 1 | 1998 | 233 |
Why?
| Lymphocytes | 2 | 1985 | 142 |
Why?
| Fluorescent Antibody Technique | 3 | 1983 | 164 |
Why?
| Immunization, Secondary | 1 | 1994 | 31 |
Why?
| Environmental Microbiology | 1 | 1993 | 4 |
Why?
| Cell Culture Techniques | 2 | 2003 | 74 |
Why?
| Ribonucleosides | 2 | 1983 | 8 |
Why?
| T-Lymphocytes, Cytotoxic | 1 | 1994 | 52 |
Why?
| Outpatients | 2 | 1990 | 29 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 1994 | 68 |
Why?
| Base Sequence | 1 | 1998 | 371 |
Why?
| Disease Models, Animal | 2 | 1992 | 349 |
Why?
| Administration, Topical | 1 | 1993 | 57 |
Why?
| Virus Replication | 2 | 1986 | 90 |
Why?
| Macromolecular Substances | 1 | 1993 | 92 |
Why?
| Peptide Fragments | 1 | 1994 | 144 |
Why?
| Viruses | 1 | 1992 | 15 |
Why?
| Reference Values | 1 | 1993 | 278 |
Why?
| Immunoglobulins, Intravenous | 1 | 1992 | 32 |
Why?
| Disease Susceptibility | 1 | 1992 | 61 |
Why?
| Immunity | 1 | 1992 | 46 |
Why?
| Cross Infection | 1 | 1992 | 46 |
Why?
| Skin | 1 | 1993 | 177 |
Why?
| Radioimmunoprecipitation Assay | 1 | 1990 | 6 |
Why?
| Autoradiography | 1 | 1990 | 73 |
Why?
| Hemagglutination Inhibition Tests | 1 | 2010 | 28 |
Why?
| Precipitin Tests | 1 | 1990 | 81 |
Why?
| Viral Nonstructural Proteins | 1 | 1990 | 8 |
Why?
| Antibody Affinity | 1 | 2009 | 11 |
Why?
| Dose-Response Relationship, Drug | 1 | 1993 | 431 |
Why?
| Species Specificity | 2 | 1987 | 186 |
Why?
| Placebos | 1 | 2010 | 110 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2009 | 31 |
Why?
| Kaplan-Meier Estimate | 1 | 2010 | 89 |
Why?
| Interleukin-1 | 1 | 1991 | 109 |
Why?
| RNA, Small Interfering | 1 | 2010 | 116 |
Why?
| Cercopithecus aethiops | 1 | 2009 | 67 |
Why?
| Vaccines, Inactivated | 1 | 1988 | 15 |
Why?
| Lymphocyte Activation | 1 | 1991 | 137 |
Why?
| Rabbits | 1 | 1990 | 252 |
Why?
| Cricetinae | 1 | 2009 | 130 |
Why?
| Monocytes | 2 | 1985 | 124 |
Why?
| Immune Sera | 1 | 1987 | 56 |
Why?
| Cell Membrane | 1 | 1990 | 170 |
Why?
| Interleukin-5 | 1 | 2007 | 20 |
Why?
| Phytohemagglutinins | 1 | 2007 | 25 |
Why?
| Croatia | 1 | 2006 | 2 |
Why?
| Models, Biological | 1 | 1993 | 410 |
Why?
| Sputum | 1 | 2007 | 26 |
Why?
| Epithelial Cells | 1 | 2009 | 135 |
Why?
| Recombinant Proteins | 1 | 2009 | 290 |
Why?
| Membrane Fusion | 1 | 1986 | 17 |
Why?
| Interleukin-4 | 1 | 2007 | 62 |
Why?
| Immunity, Active | 1 | 1985 | 8 |
Why?
| Cytotoxicity Tests, Immunologic | 1 | 1985 | 23 |
Why?
| Transfection | 1 | 2009 | 237 |
Why?
| Mice, Inbred ICR | 1 | 1985 | 34 |
Why?
| Polymerase Chain Reaction | 1 | 2007 | 279 |
Why?
| Cell Fusion | 1 | 1984 | 19 |
Why?
| Child | 3 | 1989 | 749 |
Why?
| Amino Acids | 1 | 1985 | 108 |
Why?
| Nucleoproteins | 1 | 1983 | 10 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2005 | 91 |
Why?
| Evaluation Studies as Topic | 1 | 2003 | 178 |
Why?
| Liver Neoplasms, Experimental | 1 | 1983 | 21 |
Why?
| Immunoassay | 1 | 1983 | 32 |
Why?
| Antigens, Bacterial | 1 | 1983 | 44 |
Why?
| Membrane Proteins | 2 | 1983 | 233 |
Why?
| Temperature | 1 | 1983 | 137 |
Why?
| Cattle | 1 | 1983 | 176 |
Why?
| Convalescence | 1 | 2001 | 15 |
Why?
| Serum Amyloid A Protein | 1 | 2001 | 15 |
Why?
| Respiratory Sounds | 1 | 2001 | 15 |
Why?
| Immunoglobulin Isotypes | 2 | 1987 | 17 |
Why?
| Toll-Like Receptor 4 | 1 | 2000 | 14 |
Why?
| Rats | 2 | 1983 | 530 |
Why?
| Injections, Intramuscular | 2 | 1986 | 43 |
Why?
| Toll-Like Receptors | 1 | 2000 | 19 |
Why?
| Length of Stay | 1 | 2002 | 166 |
Why?
| Dendritic Cells | 1 | 2002 | 60 |
Why?
| Statistics, Nonparametric | 1 | 2001 | 141 |
Why?
| Inflammation Mediators | 1 | 2000 | 56 |
Why?
| Herpesvirus 4, Human | 1 | 1999 | 34 |
Why?
| Kidney | 1 | 1983 | 223 |
Why?
| Tumor Virus Infections | 1 | 1999 | 31 |
Why?
| Mice, SCID | 1 | 1999 | 61 |
Why?
| Herpesviridae Infections | 1 | 1999 | 25 |
Why?
| Immunoblotting | 1 | 1999 | 119 |
Why?
| Drug Administration Schedule | 1 | 2000 | 191 |
Why?
| Case-Control Studies | 1 | 2001 | 283 |
Why?
| Regression Analysis | 1 | 2000 | 256 |
Why?
| Biological Markers | 1 | 2001 | 262 |
Why?
| Spleen | 1 | 1999 | 129 |
Why?
| Longitudinal Studies | 2 | 1987 | 195 |
Why?
| Mice, Knockout | 1 | 2000 | 265 |
Why?
| Cross-Sectional Studies | 1 | 1999 | 253 |
Why?
| Analysis of Variance | 1 | 1999 | 339 |
Why?
| Sigmodontinae | 1 | 1994 | 3 |
Why?
| Mucous Membrane | 1 | 1994 | 37 |
Why?
| Respiratory System | 1 | 1994 | 30 |
Why?
| Random Allocation | 2 | 1983 | 160 |
Why?
| Blood Donors | 1 | 1992 | 19 |
Why?
| Receptors, Transferrin | 1 | 1991 | 14 |
Why?
| Receptors, Interleukin-2 | 1 | 1991 | 31 |
Why?
| HLA-DR Antigens | 1 | 1991 | 37 |
Why?
| Pulse | 1 | 1990 | 23 |
Why?
| Population Surveillance | 1 | 1990 | 70 |
Why?
| Respiration | 1 | 1990 | 78 |
Why?
| Carbon Dioxide | 1 | 1990 | 90 |
Why?
| Cell Cycle | 1 | 1991 | 121 |
Why?
| Clinical Trials as Topic | 2 | 1983 | 251 |
Why?
| Cell Survival | 1 | 1991 | 229 |
Why?
| Infant, Premature | 1 | 1990 | 70 |
Why?
| Multivariate Analysis | 1 | 1990 | 225 |
Why?
| Flow Cytometry | 1 | 1991 | 216 |
Why?
| Prevalence | 1 | 1990 | 281 |
Why?
| Sulfur Radioisotopes | 1 | 1987 | 24 |
Why?
| Vaccinia virus | 1 | 1987 | 22 |
Why?
| Immunity, Maternally-Acquired | 1 | 1987 | 12 |
Why?
| Oxygen | 1 | 1990 | 179 |
Why?
| Methionine | 1 | 1987 | 38 |
Why?
| Aotus trivirgatus | 1 | 1985 | 2 |
Why?
| Immunity, Innate | 1 | 1987 | 60 |
Why?
| Leukocyte Count | 1 | 1985 | 94 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 1985 | 38 |
Why?
| T-Lymphocytes, Regulatory | 1 | 1985 | 32 |
Why?
| Neutrophils | 1 | 1986 | 114 |
Why?
| Respiratory Function Tests | 1 | 1983 | 72 |
Why?
| Microbial Sensitivity Tests | 1 | 1983 | 71 |
Why?
| Ribonucleoproteins | 1 | 1983 | 21 |
Why?
|
|
Walsh's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
